We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Telerobotic System Treats Bladder Cancer Better

By HospiMedica International staff writers
Posted on 18 Apr 2013
A prototype telerobotic platform provides surgeons with an improved view of bladder tumors for more accurate diagnose and treatment. More...


The prototype device, developed by researchers at Vanderbilt University (Nashville, TN, USA) and Columbia University (New York, NY, USA), is designed to be inserted through natural orifices, in this case the urethra. The device is the size and shape of a large Thermos bottle, but the operational head is only 5.5 millimeters in diameter, and consists of a segmented robotic arm which curve through 180 degrees, allowing it to point in every direction, including directly back at the entry point. At the tip is a light source, a fiberscope for observation, an optical fiber laser for cauterization, and forceps for gripping tissue.

Position of the snake-like arm can be controlled with submillimeter precision, and the fiberscope produces a 10,000-pixel image directed to a digital video camera system. Because it is steerable, the instrument is able to provide close-up views of the bladder walls at favorable viewing angles. In the future, the researchers intend to incorporate additional imaging methods for improving the ability to identify tumor boundaries. These will include fluorescence, ultrasound, and infrared (IR) optical coherence tomography (OCT) to augment the surgeon's natural vision.

In addition to these observational methods, the researchers have provided the robotic arm with force-feedback, which allows them to haptically measure the force acting on the tip when it comes into contact with tissue. New algorithms allow the robotics to accurately trace a tumor's edge, based on differential pressure readings derived from the cancerous tissue’s character. The study describing the prototype was published in the April 2013 issue of IEEE Transactions on Biomedical Engineering.

“Surgeons can typically identify the gross visual margin of a tumor within a millimeter, but a robot like this has the potential of doing so with submillimetric precision, and additional technologies may actually be able to distinguish margins at the cellular level,” said study coauthor S. Duke Herrell, PhD, associate professor of urologic surgery and biomedical engineering at Vanderbilt University Medical Center. “The system doesn't take the judgment out of surgeons' hands; it enhances their capabilities and hopefully gives them surgical superpowers.”

Bladder cancer, a significant cause of morbidity and mortality worldwide, presents a unique opportunity for aggressive treatment due to the ease of transurethral accessibility. However, while the location affords advantages, transurethral resection of bladder tumors can pose a difficult challenge for surgeons encumbered by current instrumentation or difficult anatomic tumor locations.

Related Links:

Vanderbilt University
Columbia University



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.